Christensen, M., Kamson, D. O., Snyder, M., Kim, H., Robinette, N. L., Mittal, S., & Juhász, C. (2014). Tryptophan PET-defined gross tumor volume offers better coverage of initial progression than standard MRI-based planning in glioblastoma patients. J Radiat Oncol.

Christensen, Michael, David Olayinka Kamson, Michael Snyder, Harold Kim, Natasha L. Robinette, Sandeep Mittal, och Csaba Juhász. "Tryptophan PET-defined Gross Tumor Volume Offers Better Coverage of Initial Progression Than Standard MRI-based Planning in Glioblastoma Patients." J Radiat Oncol 2014.

Christensen, Michael, et al. "Tryptophan PET-defined Gross Tumor Volume Offers Better Coverage of Initial Progression Than Standard MRI-based Planning in Glioblastoma Patients." J Radiat Oncol 2014.